Clinical Trial Update: Study of AzaSite (Azithromycin) Versus Vigamox in the Conjunctiva of Healthy Volunteers [Phase 4]

View source ↗

Summary

Phase 4 trial comparing ophthalmic azithromycin (AzaSite) with moxifloxacin (Vigamox) in healthy volunteers has completed and results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infections
• Eye Infections

Drugs mentioned

• AZASITE (AZITHROMYCIN MONOHYDRATE)
• VIGAMOX (Moxifloxacin hydrochloride)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Bacterial Infections, Eye Infections | Phase 4 | Status: COMPLETED | Results posted: 2011-07-26